Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

2025 Annual Report

Mar 31, 2026 · Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 31, 2026

On 6ix: 6ix.com/news/2025-annual-report-176

2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Announcement on Voluntary Disclosure of the Latest Data of Suvozertinib as First-Line Treatment for EGFR PACC or Other Rare Mutant Non-Small Cell Lung Cancer Released at the 2026 European Lung Cancer Conference (ELCC)Mar 28
Announcement on Voluntary Disclosure of Positive Top-line Results from the International Multicenter Phase III Clinical Trial of Shuvozhe Monotherapy as First-line Treatment for EGFR exon20ins Non-small Cell Lung CancerMar 23
Announcement on Early Return of Idle Raised Funds for Temporary Supplementary Working CapitalMar 7
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Listing and Circulation of Shares from the 2nd Exercise Window of the 2nd Exercise Period under the 2020 Employee Stock Option PlanFeb 7

Later from Dizal (Jiangsu) Pharmaceutical

Announcement on the 2nd Vesting Results in the 3rd Vesting Period for Category I Incentive Objects of Those Initially Granted in the 2022 Restricted Stock Incentive Plan and Stock ListingApr 10
Announcement on Resolutions of the 2025 Annual General MeetingApr 21
Dizal to Report Key Progress in its NSCLC Portfolio with Two Oral Presentations and a Poster During ASCO 2026Apr 21
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood ConferenceApr 29
Report for Q1 2026Apr 30

All Dizal (Jiangsu) Pharmaceutical news releases

Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.

Follow Dizal (Jiangsu) Pharmaceutical